Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
ATG101 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
ATG101 an protein required for autophagosome formation. Interacts with ATG13. Associates with a complex composed of ATG13, ULK1 and RB1CC1. Under starvation conditions it localizes to phagophores, which are preautophagosomal structures. Stabilizes the expression of Atg13 in the cell. Belongs to the ATG101 family. Note: This description may include information from UniProtKB.
Protein type: Autophagy
Molecular Function: identical protein binding; protein binding; protein complex binding
Biological Process: autophagic vacuole formation
Reference #:  Q9BSB4 (UniProtKB)
Alt. Names/Synonyms: ATG101; Atg13-interacting protein; ATGA1; Autophagy-related protein 101; C12orf44; chromosome 12 open reading frame 44; FLJ11773
Gene Symbols: ATG101
Molecular weight: 25,003 Da
Basal Isoelectric point: 5.81  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

ATG101

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 K105-u MSLEFYQkKKSRWPF
0 1 N160 INIVEVMNRHEyLPK
0 23 Y164-p EVMNRHEyLPKMPTQ
  mouse

 
K105 MSLEFYQKKKSRWPF
S160-p INIVEVMsRHEyLPK
Y164-p EVMsRHEyLPKMPTQ
  rat

 
K105 MSLEFYQKKKSRWPF
S160 INIVEVMSRHEYLPK
Y164 EVMSRHEYLPKMPTQ
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.